Drug Product and Finished Goods Capacity Update – September 2026

Home | Drug Product and Finished Goods Capacity Update – September 2026

Explore FUJIFILM Biotechnologies’ end-to-end commercial drug product filling and packaging capabilities across our global operational network; a network purpose-built with state-of-the-art technologies to safeguard our partner’s products and ensure seamless drug delivery to patients.

Watch now to hear how FUJIFILM Biotechnologies is reducing risk and complexity to our partner’s Drug Product supply chains through:

    • Co-located Drug Substance, Drug Product, and Finished Goods capacity to streamline supply and accelerate product delivery.

    • Advanced protection of our customer’s product through novel technologies designed to detect manufacturing risks in real-time.

    • Flexible packaging and autoinjector device assembly capabilities to address the next generation of drug delivery needs.

    • A global fill and finish network, built with our kojoX™ philosophy, enabling seamless scale-up or product transfers between sites.

Primary Interest(Required)
Segments(Required)
Sub-Segments(Required)
Privacy Policy(Required)
By submitting this form I agree that FUJIFILM Biotechnologies may process my data in the manner described in FUJIFILM’s Privacy Policy